Acquisition by Mark Wilson of 67150 shares of Nektar Therapeutics at 13.22 subject to Rule 16b-3
| L Stock | CAD 181.70 0.25 0.14% |
About 62% of Loblaw Companies' investor base is looking to short. The analysis of current outlook of investing in Loblaw Companies Limited suggests that many traders are alarmed regarding Loblaw Companies' prospects. Loblaw Companies' investing sentiment overview a quick insight into current market opportunities from investing in Loblaw Companies Limited. Many technical investors use Loblaw Companies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Loblaw |
Filed transaction by Nektar Therapeutics Officer Svp General Counsel. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Loblaw Companies' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Loblaw Companies' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Loblaw Companies Fundamental Analysis
We analyze Loblaw Companies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Loblaw Companies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Loblaw Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Loblaw Companies is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Loblaw Companies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Loblaw Companies stock to make a market-neutral strategy. Peer analysis of Loblaw Companies could also be used in its relative valuation, which is a method of valuing Loblaw Companies by comparing valuation metrics with similar companies.
Peers
Loblaw Companies Related Equities
| CTC-A | Canadian Tire | 0.94 | ||||
| DOL | Dollarama | 0.73 | ||||
| WN | George Weston | 0.63 | ||||
| CNR | Canadian National | 0.01 | ||||
| MRU | Metro | 1.21 |
Other Information on Investing in Loblaw Stock
Loblaw Companies financial ratios help investors to determine whether Loblaw Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Loblaw with respect to the benefits of owning Loblaw Companies security.